{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:52:06Z","timestamp":1784130726615,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.amjcard.2023.06.054","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:55:33Z","timestamp":1689008133000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Percutaneous Left Atrial Appendage Closure Among Patients With Diabetes (Insights from a National Database)"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2010-0394","authenticated-orcid":false,"given":"Mohamed","family":"Hamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez","family":"Morcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Jneid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Khalife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijeshwar","family":"Maini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houman","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.06.054_bib0001","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in atrial fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0002","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0003","first-page":"255","article-title":"The epidemiology of atrial fibrillation and stroke","volume":"34","author":"Pistoia","year":"2016","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijcard.2017.08.049","article-title":"Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation","volume":"249","author":"Gloekler","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0006","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00059-019-04880-4","article-title":"Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation","volume":"46","author":"Liu","year":"2021","journal-title":"Herz"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0007","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jacc.2015.06.028","article-title":"2015 ACC\/HRS\/SCAI LAA Occlusion Device Societal Overview","volume":"66","author":"Masoudi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0008","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0009","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0010","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/jce.14182","article-title":"Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation","volume":"30","author":"Black-Maier","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0011","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: A pooled, patient-level analysis of the WATCHMAN randomized trial experience","volume":"8","author":"Price","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0012","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17434440.2020.1781615","article-title":"The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives","volume":"17","author":"Wintgens","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0013","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus: JACC review topic of the week","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0014","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijcard.2015.03.052","article-title":"Diabetes mellitus and atrial fibrillation: pathophysiological mechanisms and potential upstream therapies","volume":"184","author":"Goudis","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0015","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0016","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2005.02.050","article-title":"Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease","volume":"105","author":"Movahed","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0017","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00125-006-0493-z","article-title":"Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database","volume":"49","author":"Mulnier","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0018","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0019","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0022","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0023","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1161\/01.CIR.96.8.2551","article-title":"Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty","volume":"96","author":"Barsness","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0024","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jacc.2012.08.993","article-title":"Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008","volume":"60","author":"Hillegass","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.athoracsur.2010.03.111","article-title":"The effect of diabetes mellitus on in-hospital and long-term outcomes after heart valve operations","volume":"90","author":"Halkos","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0026","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/1479164117712176","article-title":"Percutaneous closure of the left atrial appendage in patients with diabetes mellitus","volume":"14","author":"Azizy","year":"2017","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0027","series-title":"Clinical Classifications for Health Policy Research. Version 2: Hospital inpatient statistics","author":"Elixhauser","year":"1996"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0028","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12913-015-1025-7","article-title":"A comparison of a multistate inpatient EHR database to the HCUP Nationwide Inpatient Sample","volume":"15","author":"DeShazo","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0029","unstructured":"AHRQ. HCUP Nationwide Inpatient Sample (NIS): Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2007 to 2009. Available at: https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp. Accessed on Novemeber 27, 2022."},{"key":"10.1016\/j.amjcard.2023.06.054_bib0030","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.hrthm.2021.05.017","article-title":"Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: prevalence, predictors, and associated in-hospital adverse events from 17,700 procedures in the United States","volume":"18","author":"Munir","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0031","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.hroo.2021.08.002","volume":"2","author":"Munir","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0032","unstructured":"AHRQ. Cost-to-Charge Ratio Files: User Guide for Nationwide Readmissions Database (NRD) CCRs; 2019. Available at: https:\/\/hcup-us.ahrq.gov\/db\/ccr\/costtocharge.jsp. Accessed on September 4, 2022."},{"key":"10.1016\/j.amjcard.2023.06.054_bib0033","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1755-5922.12089","article-title":"Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies","volume":"32","author":"Zhang","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/clc.23292","article-title":"Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation","volume":"43","author":"Yosefy","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamacardio.2016.5224","article-title":"Atrial fibrillation, Type 2 diabetes, and non-vitamin K antagonist oral anticoagulants: a review","volume":"2","author":"Plitt","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0036","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-444-53480-4.00012-6","article-title":"Stroke and diabetes mellitus","volume":"126","author":"Hill","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0037","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11239-011-0555-z","article-title":"Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure","volume":"31","author":"Lee","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0038","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0039","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0041","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0042","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2337\/dc18-2472","article-title":"Association of diabetes and glycated hemoglobin with the risk of intracerebral hemorrhage: a population-based cohort study","volume":"42","author":"Saliba","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0043","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.jacc.2016.02.082","article-title":"Nonvitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF","volume":"67","author":"Chan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0044","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5482\/HAMO-14-08-0036","article-title":"Anticoagulation in patients with impaired renal function and with haemodialysis. Anticoagulant effects, efficacy, safety, therapeutic options","volume":"35","author":"Harenberg","year":"2015","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0045","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0046","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0047","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1161\/01.CIR.97.17.1695","article-title":"Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo","volume":"97","author":"Williams","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0048","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0003-4975(97)01003-5","article-title":"Mediastinitis after cardiovascular operations: a case-control study of risk factors","volume":"65","author":"Bitkover","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0049","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0022-5223(19)38882-8","article-title":"Diabetes mellitus and coronary artery bypass. Short-term risk and long-term prognosis","volume":"85","author":"Salomon","year":"1983","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0050","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.athoracsur.2011.09.073","article-title":"Risk factors for perioperative acute kidney injury after adult cardiac surgery: role of perioperative management","volume":"93","author":"Parolari","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0051","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.semtcvs.2006.04.004","article-title":"The diabetic disadvantage: historical outcomes measures in diabetic patients undergoing cardiac surgery - the pre-intravenous insulin era","volume":"18","author":"Brown","year":"2006","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0052","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0053","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.054_bib0054","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923004484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923004484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:47:56Z","timestamp":1757573276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923004484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":54,"alternative-id":["S0002914923004484"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.054","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous Left Atrial Appendage Closure Among Patients With Diabetes (Insights from a National Database)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}